维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="ASSENAT E"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Nutritional support during oncologic treatment of patients with gastrointestinal cancer:who could benefit?显示文摘	SENESSE P ASSENAT E SCHNEIDER S	2008	Cancer Treat Rev2008，34，6：	1
2	EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer 显示文摘	Ho-Pun-Cheung A Assenat E Bascoul-Mollevi C	2011	Int J Cancer2011，128，12：	1
3	Effect of everolimus on sur- vival in advanced hepatocellular carcinoma after failure of sor- afenib: the EVOLVE-1 randomized clinical trim 显示文摘	Zhu AX Kudo M Assenat E	2014	JAMA2014，312，1：	1
4	Is nuclear factor kappa-B the missing link between inflammation,cancer and alteration in hepatic drug metabolism in patients with cancer?显示文摘	Assenat E Gerbal-Chaloin S Manrel P	2006	European Journal of Cancer2006，42，：	1
5	Irinotecan for the treatment of metastatic colorectal cancer显示文摘	Assenat E Duffour J Ychou M	2006	Bull Cancer2006，93，5：	1
6	Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit显示文摘	Senesse P Assenat E Schneider S	2008	Cancer Treat Rev2008，34，6：	1
7	Value of MRCP for diagnosis of biliary complications after liver transplantation 显示文摘	Aufort S Molina E Assenat E	2008	J Radiol2008，89，21：	1
8	Nutritional support during oncologic treatment of patients with gastrointestinal cancer: Who could benefit显示文摘	Senesse P Assenat E Schneider S	2008	Cancer Treat Rev2008，34，6：	1
9	A large-scale candidate gene approach identifies SNPs in SOD 2 and IL 1 3 as predictivemarkers of response to preoperative chemoradiation in rectal cancer 显示文摘	Ho-Pun-Cheung A Assenat E Bascoul-Mollevi C	2011	Pharmacogenomics J2011，1，：	1
10	Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial 显示文摘	Assenat E Desseigne F Thezenas S	2011	Oncologist2011，16，11：	1
11	Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the 'THERAPY' phase 1-2 trial 显示文摘	Assenat E Azria D Mollevi C	2015	On- cotarget2015，6，12：	1
12	Interleukin lbeta inhibits CAR - induced expression of he- patic genes involved in drug and bilirubin clearance显示文摘	Assenat E	2004	Hepatology2004，40，4：	1
13	Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer:a phase Ⅱ trial显示文摘	Assenat E Desseigne F Thezenas S	2011	Oncologist2011，16，：	1
14	Nutritional support during oncologic treatment of patients with gastrointestinal cancer: who could benefit 显示文摘	Senesse P Assenat E Schneider S	2008	Cancer Treat Rev2008，34，6：	1
15	Cetuximab plus FOLFIRINOX (ERBIRINOX)as first-line treatment for unresectable metastatic colorectal cancer:a phase Ⅱ trial显示文摘	Assenat E Desseigne F Thezenas S	2011	Oncolagist2011，16，11：	1
16	Nutritional support during oncologic treatment of patients with gastrointestinal cancer:Who could benefit ?显示文摘	Senesse P Assenat E Schneider S	2008	Cancer Treat Rev2008，3，4：	1
17	Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib 显示文摘	Zhu AX Kudo M Assenat E	2014	J Clin Oncol2014，32，3：	1
18	The value of endoscopic rectal ultrasound in predicting the lateral clearance and outcome in patients with lower-third rectal ade- nocarcinoma 显示文摘	Assenat E Thrzenas S Samalin E	2007	Endoscopy2007，39，4：	1
19	Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance 显示文摘	Assenat E Gerbal-Chaloin S Larrey D	2004	Hepatology2004，40，4：	1
20	Effect of everolimus on survival in advanced hepatocellular carcinoma after failure o\| sorafenib: the EVOLVE-1 randomized clinical trial 显示文摘	Zhu AX Nudo M Assenat E	2014	JAMA2014，312，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示